Business Description
Medicover AB
ISIN : SE0009778848
Share Class Description:
OSTO:MCOV B: Class BCompare
Compare
Traded in other countries / regions
MCOV B.Sweden5M0B.Germany0RPS.UKMCVEY.USA IPO Date
2017-05-23Description
Medicover AB is an international healthcare and diagnostic services, provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. The company offers its services through two segments; Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas in Germany, Romania, Poland, and Ukraine, and Healthcare Services offer high-quality care based on an Integrated Healthcare Model and Fee-For-Service in Poland, India, and Romania. It generates maximum revenue from the Healthcare Services segment. Geographically, it derives a majority of its revenue from Poland and also has a presence in Romania; Germany; Ukraine; India, and Other Countries.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.08 | |||||
| Equity-to-Asset | 0.25 | |||||
| Debt-to-Equity | 2.11 | |||||
| Debt-to-EBITDA | 3.95 | |||||
| Interest Coverage | 1.34 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.07 | |||||
| Beneish M-Score | -2.8 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 22.2 | |||||
| 3-Year EBITDA Growth Rate | 20.9 | |||||
| 3-Year EPS without NRI Growth Rate | -25 | |||||
| 3-Year FCF Growth Rate | 6 | |||||
| 3-Year Book Growth Rate | 6.5 | |||||
| Future 3-5Y Total Revenue Growth Rate | 16.38 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 90.42 | |||||
| 9-Day RSI | 85.61 | |||||
| 14-Day RSI | 80.52 | |||||
| 6-1 Month Momentum % | 1.49 | |||||
| 12-1 Month Momentum % | -23.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.75 | |||||
| Quick Ratio | 0.64 | |||||
| Cash Ratio | 0.16 | |||||
| Days Inventory | 14.11 | |||||
| Days Sales Outstanding | 44.3 | |||||
| Days Payable | 43.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.81 | |||||
| Dividend Payout Ratio | 0.83 | |||||
| Forward Dividend Yield % | 0.81 | |||||
| 5-Year Yield-on-Cost % | 0.81 | |||||
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | -4.93 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 20.51 | |||||
| Operating Margin % | 3.81 | |||||
| Net Margin % | 1.2 | |||||
| FCF Margin % | 6.24 | |||||
| ROE % | 4.53 | |||||
| ROA % | 1.16 | |||||
| ROIC % | 3.01 | |||||
| ROC (Joel Greenblatt) % | 9.21 | |||||
| ROCE % | 5.63 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 107.59 | |||||
| PE Ratio without NRI | 107.59 | |||||
| Shiller PE Ratio | 88.37 | |||||
| Price-to-Owner-Earnings | 18.35 | |||||
| PEG Ratio | 5.05 | |||||
| PS Ratio | 1.3 | |||||
| PB Ratio | 4.72 | |||||
| Price-to-Free-Cash-Flow | 20.79 | |||||
| Price-to-Operating-Cash-Flow | 10.65 | |||||
| EV-to-EBIT | 41.67 | |||||
| EV-to-Forward-EBIT | 27.94 | |||||
| EV-to-EBITDA | 12.58 | |||||
| EV-to-Forward-EBITDA | 9.57 | |||||
| EV-to-Revenue | 1.85 | |||||
| EV-to-Forward-Revenue | 1.39 | |||||
| EV-to-FCF | 29.59 | |||||
| Price-to-Projected-FCF | 1.75 | |||||
| Price-to-Peter-Lynch-Fair-Value | 5.01 | |||||
| Earnings Yield (Greenblatt) % | 2.4 | |||||
| FCF Yield % | 4.82 | |||||
| Forward Rate of Return (Yacktman) % | 23.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medicover AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 20,977.911 | ||
| EPS (TTM) (kr) | 1.686 | ||
| Beta | 0 | ||
| Volatility % | 43.55 | ||
| 14-Day RSI | 80.52 | ||
| 14-Day ATR (kr) | 6.812094 | ||
| 20-Day SMA (kr) | 144.94 | ||
| 12-1 Month Momentum % | -23.2 | ||
| 52-Week Range (kr) | 118.3 - 188.4 | ||
| Shares Outstanding (Mil) | 149.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medicover AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medicover AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medicover AB Frequently Asked Questions
What is Medicover AB(OSTO:MCOV B)'s stock price today?
The current price of OSTO:MCOV B is kr181.40. The 52 week high of OSTO:MCOV B is kr188.40 and 52 week low is kr118.30.
When is next earnings date of Medicover AB(OSTO:MCOV B)?
The next earnings date of Medicover AB(OSTO:MCOV B) is 2024-07-25.
Does Medicover AB(OSTO:MCOV B) pay dividends? If so, how much?
The Dividend Yield %  of Medicover AB(OSTO:MCOV B) is 0.81% (As of Today), Highest Dividend Payout Ratio of Medicover AB(OSTO:MCOV B) was 1.58. The lowest was 0.1. And the median was 1.19. The  Forward Dividend Yield % of Medicover AB(OSTO:MCOV B) is 0.81%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers